Winter 2023/2024 Vol. 13 Issue 04
-
From the Editor-in-Chief
Cancer Treatment: Can Less Be More?Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
The Reality of Chemo BrainLearn ways to work through moments of fogginess and forgetfulness as you recover from cancer.
by Hester Hill Schnipper
-
Caregiving With Confidence
Falling ShortPeople feeling overwhelmed by caregiving responsibilities can help ease the burden if they learn to ask for help.
by K.J. Bannan
-
Policy Matters
Taking Action to Support Cancer ResearchThe AACR releases AACR Cancer Progress Report 2023, announces Cancer Centers Alliance, and joins 11th Rally for Medical Research.
by Benjamin Krinsky, PhD
-
Controlling Peripheral Neuropathy
Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.
by Cameron Walker
-
Moving the Needle on Metastatic Breast Cancer
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
by Erin O’Donnell
-
Progress in Rare Cancers
With the rise of patient-driven research and registries, scientists are making advances in understanding, diagnosing and treating many of the least common cancer types.
by Kendall K. Morgan
-
Survivor Profile
A Can-Do SpiritNavy veteran and two-time cancer survivor Bruce Wright helps other veterans secure benefits for their health conditions.
by Lindsey Konkel Neabore
-
Get Involved
A Helping HandThe Singletons take care of the shopping so single parents can focus on their cancer treatments.
by Thomas Celona
-
Facts and Stats
Cancer’s Economic ImpactBetween 2020 and 2050, cancer is expected to cost the global economy $25 trillion.
by Thomas Celona
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon